Bravida Medical

Bravida Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $25M

Overview

Bravida Medical is a commercial-stage medical device company building a portfolio of clinically-proven products for infection prevention and advanced wound care. Its core technology leverages antimicrobial silver and other agents across dressings, cleansers, and securement devices targeting high-burden areas like surgical sites, vascular access, burns, and urology. The company demonstrates commercial traction, impacting millions of patient and healthcare professional lives annually, and actively publishes clinical evidence to support its products' use in complex care settings such as ventricular assist device (VAD) driveline and ECMO cannula site management.

Infection PreventionWound CareUrologyVascular AccessSurgical CareBurn Care

Technology Platform

Application of antimicrobial agents (silver, chlorhexidine) in specialized dressings, cleansers, and securement devices for infection prevention and wound management.

Funding History

2
Total raised:$25M
Series A$20M
Seed$5M

Opportunities

Large and growing markets for HAIs and chronic wounds, with a specific high-value niche in preventing infections associated with advanced therapies like LVAD and ECMO.
Opportunity to establish new standards of care through continued clinical evidence generation and to leverage a multi-brand portfolio for cross-selling and integrated solutions.

Risk Factors

Intense competition from large medtech firms and potential commoditization of silver-based dressings.
Dependence on generating conclusive clinical data to drive adoption and secure reimbursement.
Execution risks associated with integrating and commercializing a multi-brand portfolio across complex hospital procurement pathways.

Competitive Landscape

Bravida competes in crowded segments against major players like 3M, Smith & Nephew, ConvaTec, and Coloplast in wound care and infection prevention. Its differentiation hinges on specialized applications (e.g., VAD/ECMO securement), its specific silver-plated nylon technology, and a focused clinical evidence strategy targeting high-acuity complications.